FDA partners with PHREB-recommended ERBs in regulatory review of clinical trials

FDA Circular 2012-007 released last June 7, 2012.

“Clinical trials are conducted to evaluate the effectiveness and safety of new medications or medical devices. This is the bridge we need to take before introducing them for public use. Clinical trials should be carefully designed to ensure that no human is harmed or abused during the study period,” explained Dr. Suzette H. Lazo, Former Director of the FDA during the 6th Philippine National Health Research System Week celebration.

Follow Us
Contact Us
Saliksik Building, Science Community Complex Gen. Santos Ave., Bicutan, Taguig City 1631
info@pchrd.dost.gov.ph, feedback@pchrd.dost.gov.ph
Trunk Lines: 8837-2931; 8837-0087; 8837-2924
Direct Lines: 8837-2942; 8837-7536; 8837-0031; 8837-7535; 8837-7534; 8837-7537
Map and Location
Skip to content